03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Somatuline LP* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | Ipsen Pharma |
Responsible Party | Ipsen Pharma Biotech |
Origin | France |
Manufacturer | Ipsen Pharma Biotech |
Origin | France |
ATC | H01CB03 |
Revision Date | 01/01/2003 |
Somatuline LP* :
Somatuline LP* :
Somatuline LP* :
Somatuline LP* :
Somatuline LP* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Somatuline LP* :
Somatuline LP* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal discomfort | Common |
Abdominal distension | Common |
Abdominal pain | Very Common |
Alanine aminotransferase abnormal | Common |
Allergic reaction | Not known |
Alopecia | Common |
ALT increased | Common |
Anaphylaxis | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Not known |
AST abnormal | Common |
AST increased | Uncommon |
Asthenia | Common |
Biliary dilatation | Common |
Blood alkaline phosphatase increased | Uncommon |
Blood bilirubin abnormal | Uncommon |
Blood bilirubin increased | Common |
Blood glucose increased | Common |
Cephalea | Common |
Cholelithiasis (Calculus biliary) (Gallstones) | Very Common |
Constipation | Common |
Decreased appetite | Common |
Diabetes | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dyspepsia | Common |
Faeces discoloured (Discolored stools) | Uncommon |
Fatigue | Common |
Flatulence | Common |
Glycosylated haemoglobin increased | Common |
Hot flush | Uncommon |
Hyperglycaemia | Common |
Hypersensitivity | Not known |
Hypoglycaemia | Common |
Hyponatraemia (Hyponatremia) | Uncommon |
Hypotrichosis | Common |
Injection site induration | Common |
Injection site nodule | Common |
Injection site pain | Common |
Injection site pruritus | Common |
Insomnia | Uncommon |
Lethargy | Common |
Loose stools (Soft stools) | Very Common |
Musculoskeletal pain | Common |
Myalgia | Common |
Nausea | Common |
Pancreatic enzymes abnormal | Common |
Pancreatic enzymes decreased | Common |
Pancreatitis | Not known |
Sinus bradycardia | Common |
Steatorrhoea (Fatty stools) | Common |
Vomiting | Common |
Weight decreased (Weight loss) | Common |
Somatuline LP* :
NB : Products With Same Indication |
Different Units By MoH Code
Somatuline LP* MoH 2812 :
Form | Powder and solvent for suspension for injection |
Packaging | Vial + Ampoule |
Package Size | 1+1x2ml |
Strength | 30mg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 974465/00 |
Submission date | 01/01/2000 |
Registration Year | 2002 |
Archived Date | 2018 |
Price Comparison
● Country: | Jordan | |
● Package Size: | 1 | |
● Public Price: | 551.17 JOD | ( 69,018,058.57 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 551,17 JOD | ( 68,996,771.00 LBP ) |
● Pharmacy Price: | 420.58 JOD | ( 52665448.18 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 12/12/2018 | |
● Type: | Medicine Non Marketed |
● Country: | France | |
● Package Size: | 1 | |
● Public Price: | 587.41 EUR | ( 56,905,931.16 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 587,41 EUR | ( 56,866,212.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 1 | |
● Public Price: | 500.08 EUR | ( 48,445,750.08 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 500,08 EUR | ( 48,438,000.00 LBP ) |
● Pharmacy Price: | 493.08 EUR | ( 47767618.08 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 1 | |
● Public Price: | 435.58 EUR | ( 42,197,248.08 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 435,58 EUR | ( 42,141,060.00 LBP ) |
● Pricing Date: | 08/10/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 1 | |
● Public Price: | 323 GBP | ( 36,708,627.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 323 GBP | ( 36,708,627.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 1+1x2ml | |
● Public Price: | 373.98 EUR | ( 36,229,686.48 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 373,98 EUR | ( 36,134,748.00 LBP ) |
● Exfactory Price: | 316 EUR | |
● Pharmacy Price: | 320.74 EUR | ( 31072008.24 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 1x2ml | |
● Public Price: | 348.86 EUR | ( 33,796,161.36 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 348,86 EUR | ( 33,712,848.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File